These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35408662)

  • 1. Identification and Quantification by NMR Spectroscopy of the 22
    Kuz'mina NE; Moiseev SV; Severinova EY; Stepanov EA; Bunyatyan ND
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantification of 22R and 22S epimers of budesonide in human plasma by ultra-high-performance liquid chromatography-tandem mass spectrometry: application in a stereoselective pharmacokinetic study.
    Lu Y; Sun Z; Zhang Y; Chen X; Zhong D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 921-922():27-34. PubMed ID: 23416292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct separation, identification and quantification of epimers 22R and 22S of budesonide by capillary gas chromatography on a short analytical column with Rtx-5 stationary phase.
    Krzek J; Czekaj JS; Rzeszutko W; Jończyk A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(2):191-200. PubMed ID: 15063325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of epimers 22R and 22S of budesonide in human plasma by high-performance liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.
    Li YN; Tattam B; Brown KF; Seale JP
    J Chromatogr B Biomed Appl; 1996 Aug; 683(2):259-68. PubMed ID: 8891924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation in vitro of the 22R and 22S epimers of budesonide by human liver, bronchus, colonic mucosa and skin.
    Cortijo J; Urbieta E; Bort R; Castell JV; Ruiz-Bravo C; Martinez J; Palacios-Pelaez R; Lledó S; Morcillo EJ
    Fundam Clin Pharmacol; 2001 Feb; 15(1):47-54. PubMed ID: 11468013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An experimental and computational study on the epimeric contribution to the infrared spectrum of budesonide.
    Ali HR; Edwards HG; Kendrick J; Munshi T; Scowen IJ
    Drug Test Anal; 2010 Sep; 2(9):447-51. PubMed ID: 20812265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between chemical structure, receptor binding, and biological activity of some novel, highly active, 16 alpha, 17 alpha-acetal-substituted glucocorticoids.
    Dahlberg E; Thalén A; Brattsand R; Gustafsson JA; Johansson U; Roempke K; Saartok T
    Mol Pharmacol; 1984 Jan; 25(1):70-8. PubMed ID: 6708937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulfation of budesonide by human cytosolic sulfotransferase, dehydroepiandrosterone-sulfotransferase (DHEA-ST).
    Meloche CA; Sharma V; Swedmark S; Andersson P; Falany CN
    Drug Metab Dispos; 2002 May; 30(5):582-5. PubMed ID: 11950791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of the epimeric glucocorticoid budesonide.
    Ryrfeldt A; Edsbäcker S; Pauwels R
    Clin Pharmacol Ther; 1984 Apr; 35(4):525-30. PubMed ID: 6705451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative
    Silva RCA; de Sousa EGR; Mazzei JL; de Carvalho EM
    J Pharm Biomed Anal; 2022 Feb; 210():114585. PubMed ID: 35042143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-performance liquid chromatographic determination of epimers, impurities, and content of the glucocorticoid budesonide and preparation of primary standard.
    Roth G; Wikby A; Nilsson L; Thalén A
    J Pharm Sci; 1980 Jul; 69(7):766-70. PubMed ID: 7391935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved chemical synthesis, X-ray crystallographic analysis, and NMR characterization of (22R)-/(22S)-hydroxy epimers of bile acids.
    Omura K; Ohsaki A; Zhou B; Kushida M; Mitsuma T; Kobayashi A; Hagey LR; Hofmann AF; Iida T
    Lipids; 2014 Nov; 49(11):1169-80. PubMed ID: 25319478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quantitative
    Uchiyama N
    Yakugaku Zasshi; 2024; 144(4):359-365. PubMed ID: 38556308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of quantitative NMR in pharmaceutical analysis: Method qualification and potency determination for two new chemical entities in early-stage clinical studies.
    Guo X; Miller W; Zangi M; McElderry JD
    J Pharm Biomed Anal; 2023 Sep; 234():115561. PubMed ID: 37421701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of anti-inflammatory corticosteroids in human bone-derived osteoblast-like cells.
    Namkung-Matthäi H; Seale JP; Brown K; Mason RS
    Eur Respir J; 1998 Dec; 12(6):1327-33. PubMed ID: 9877486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of inhaled budesonide.
    Donnelly R; Seale JP
    Clin Pharmacokinet; 2001; 40(6):427-40. PubMed ID: 11475468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver metabolism of budesonide in rat, mouse, and man. Comparative aspects.
    Edsbäcker S; Andersson P; Lindberg C; Paulson J; Ryrfeldt A; Thalén A
    Drug Metab Dispos; 1987; 15(3):403-11. PubMed ID: 2886319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaborative Study to Validate Purity Determination by
    Miura T; Sugimoto N; Bhavaraju S; Yamazaki T; Nishizaki Y; Liu Y; Bzhelyansky A; Amezcua C; Ray J; Zailer E; Diehl B; Gallo V; Todisco S; Ofuji K; Fujita K; Higano T; Geletneky C; Hausler T; Singh N; Yamamoto K; Kato T; Sawa R; Watanabe R; Iwamoto Y; Goda Y
    Chem Pharm Bull (Tokyo); 2020 Sep; 68(9):868-878. PubMed ID: 32565492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative
    Uchiyama N; Kiyota K; Hosoe J; Komatsu T; Sugimoto N; Ishizuki K; Koide T; Murabayashi M; Kobayashi K; Fujimine Y; Yokose T; Ofuji K; Shimizu H; Hasebe T; Asai Y; Ena E; Kikuchi J; Fujita K; Makino Y; Iwamoto Y; Miura T; Muto Y; Asakura K; Suematsu T; Muto H; Kohama A; Goto T; Yasuda M; Ueda T; Goda Y
    Chem Pharm Bull (Tokyo); 2022 Dec; 70(12):892-900. PubMed ID: 36223954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Application of Quantitative ¹H-NMR for the Determination of Orlistat in Tablets.
    Sun S; Jin M; Zhou X; Ni J; Jin X; Liu H; Wang Y
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28891958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.